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Abstract
Retinal tissue is exceptional because it shows a high level of energy metabolism. Glycogen content represents the only
energy reserve in retina, but its levels are limited. Therefore, elucidation of the mechanisms controlling glycogen content in
retina will allow us to understand retina response under local energy demands that can occur under normal and
pathological conditions. Thus, we studied retina glycogen levels under different experimental conditions and correlated
them with glucose-6-phosphate (G-6-P) content and glycogen synthase (GS) activity.
Glycogen and G-6-P content were studied in ex vivo retinas from normal, fasted, streptozotocin-treated, and insulin-
induced hypoglycemic rats. Expression levels of GS and its phosphorylated form were also analyzed. Ex vivo retina from
normal rats showed low G-6-P (1462 pmol/mg protein) and glycogen levels (4363 nmol glycosyl residues/mg protein),
which were increased 6 and 3 times, respectively, in streptozotocin diabetic rats. While no changes in phosphorylated GS
levels were observed in any condition tested, a positive correlation was found between G-6-P levels with GS activity and
glycogen content. The results indicated that in vivo, retina glycogen may act as an immediately accessible energy reserve
and that its content was controlled primarily by G-6-P allosteric activation of GS. Therefore, under hypoglycemic situations
retina energy supply is strongly compromised and could lead to the alterations observed in type 1 diabetes.
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Introduction
Glucose is the main substrate for energy metabolism in nervous
tissue, including retina. Indeed, retina exhibits a high level of
energy metabolism requiring constant supply of blood glucose to
sustain function [1]. Glucose is phosphorylated to glucose-6-
phosphate (G-6-P), which is an important regulatory molecule that
enters glycolysis to provide energy via fermentation and
subsequent oxidation; after transformation into UDP-glucose, G-
6-P can be converted to glycogen. Although the function of
glycogen in the nervous system is unknown, there is evidence
which suggests that it may act as an energy source during periods
of energy deprivation [1]. In the retina, glycogen content
fluctuates as the levels of glucose change in the medium [2]. In
peripheral organs, glycogen levels are determined by the balance
between glycogen synthase (GS) and glycogen phosphorylase (GP),
which are the key enzymes for glycogen synthesis and degradation,
respectively. GS is regulated by covalent phosphorylation which
inhibits the enzyme [3], [4], and by the allosteric activator G-6-P
[5], [6], although the relative contribution of these two events in
the activation of GS is not well understood. Insulin is thought to
promote the dephosphorylation and activation of GS leading to
the stimulation of glycogen synthesis [3], [4]. However, in the
retina from streptozotocin-diabetic rats, glycogen content and GS
activity increased [7]. In diabetes, the retina is exposed to
fluctuations in blood glucose concentrations, which may be
accompanied by changes in oxygen availability and additional
metabolic disturbances. Therefore, we designed in vivo experi-
ments to investigate whether glycogen content in retina is
regulated by the GS-allosteric activator G-6-P, or if it might also
be regulated by insulin.
Materials and Methods
Animals
Adult Long Evans rats (170–200 g) were used in this study.
Animals were maintained under standard laboratory conditions
(21uC61, 12 h light dark cycle) and were allowed food and
water ad libitum. All experiments were conducted between 9:30 and
12:00 am.
All procedures were conducted in accordance with the Mexican
Institutes of Health Research (DOF. NOM-062-Z00-1999), the
National Institutes of Health Guide for the Care and Use of
Laboratory Animals (NIH publication No. 80-23, revised 1996), as
well as the Association Research in Vision and Ophthalmology
Statement on the Use of Animals in Ophthalmic and Vision
Research. The experimental protocol was approved by the
Committee on the Ethics of Animal Experiments of our
Institution. All efforts were made to minimize animal suffering,
and to reduce the number of rats used.
Diabetes was induced by intraperitoneal administration of
streptozotocin (65 mg/kg) in 0.05 M citrate buffer, pH 4.5 [8].
Animals were considered diabetic if blood glucose levels were
higher than 250 mg/dl (14 mM). Diabetic animals along with
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administration.
Insulin administration
Insulin (5 U/Kg; Humulin NPH, Lilly) was administered with a
single subcutaneous injection. Blood glucose levels were measured
prior to injection of saline (0.9% sodium chloride) or insulin, as
well as at 30, 60, 90, and 120 min post injection. At different time
points, rats were sacrificed; the eyes were quickly dissected over
ice, equatorially hemisected, and for biochemical determinations
the retina was peeled away from the optic-cup using fine forceps.
Glucose administration
Normal rats were fasted overnight for 18 h. Blood glucose levels
were measured before and after 30, 60, 90, 120, and 150 min of
intraperitoneal administration of glucose (1 g/Kg) or the same
volume of saline. Rats were sacrificed approximately 2 h after
glucose administration, when blood glucose levels were twice the
initial values; retinas were isolated as above for biochemical
determinations.
Biochemical assays
For determination of glucose-6-phosphate, tissues were rapidly
homogenized in cold 6% (w/v) perchloric acid. Protein was
removed by centrifugation and G-6-P was enzymatically quanti-
fied according to Michal, 1984 [9]. The amount of NADPH
produced was determined by the absorbance at 340 nm using an
extinction coefficient of 6.3.
For glycogen determination, tissues were quickly homogenized
with 0.4 ml of ice cold 100 mM NaOH and assayed as described
previously [10]. GS and GP activities were measured in tissue
homogenates (10% w/v) according to Dringen, 1982 [11]. GS
activity was measured in the presence of 6.2 mM of glucose-6-
phosphate. Total GP activity was determined by incubating the
tissues in the presence of 1 mM AMP [10].
Western blot analysis
Western blot analyses were performed as previously described
[7]. Equal amounts of sample were resolved on a 10% SDS
polyacrilamide gel. The proteins were transferred into PVDF
Immobilon membranes (Millipore Corp, Billerica, MA). After
being blocked with 5% nonfat milk, the membranes were probed
with rabbit anti-glycogen synthase 15B1 (1:500, Cell Signaling
Technology, Danvers, MA), or rabbit anti-phospho glycogen
synthase (Ser641) (1:100, Cell Signaling Technology, Danvers,
MA), followed by horseradish-peroxidase-conjugated secondary
antibody (1:4000, Amersham Biosciences Piscataway, NJ). Protein
loading was normalized to actin using a monoclonal primary
antibody (1:25000, Chemicon, Temecula, CA). The signal was
detected by enhanced chemioluminiscence using Chemioluminis-
cent HRP Substrate (Millipore Corp, Billerica, MA). Densitometry
was performed with an Alpha DigiDoc RT (Alpha Innotech, San
Leandro, CA) and analysed using a densitometry program
(AlphaEase FC Stand Alone; Alpha Innotech, San Leandro, CA).
Protein content was determined using a commercial assay kit
(BioRad Lab. Hercules, CA). Blood glucose concentration was
determined with a blood glucose monitor (Accu-check, Roche,
Indianapolis, IN).
Statistical analysis
All results are presented as the standard error of the mean 6
SEM of at least five separate experiments. Significance was
determined by analysis of the variance (ANOVA) using Tukey’s
post hoc test or Student’s t –test, where p,0.05 was taken to
indicate statistical significance.
Results
Previous results indicated that glycogen content in retina
fluctuated as the level of glucose changed in the incubation
medium [2]. Thus, in order to gain insight into the regulation of
glycogen content in vivo, we studied glycogen levels and those of the
GS- allosteric- activator G-6-P under different conditions.
As shown in Table 1, ex vivo retinas from normal rats exhibited
low G-6-P (1462 pmol/mg protein), values that were considerably
reduced in the retina from fasted rats (1.860.5 pmol/mg protein)
(Table 1). In contrast, G-6-P content increased 6 times the control
value in the retina from streptozotocin-diabetic rats as well as in
fasting rats after glucose administration (Table 1). Confirming a
previous report [7], we found glycogen content in retina of
diabetic rats increased about 3 times over control levels (Table 1).
However, glycogen levels in fasting rats or in fasting rats injected
with glucose were similar to those observed in normal rat retina
(Table 1).
Because net content of glycogen is regulated simultaneously by
both synthesis and breakdown, we determined the activity of GS
and GP in the retina of normal and of diabetic rats. The activity
of GS was found to be increased (60%) in the retina from
streptozotocin-diabetic rats, while no significant changes were
observed in the activity of GP (Table 2) [7]. Since GS activity is
known to be stimulated by dephosphorylation [3], [4], we
determined levels of phosphorylated- GS form (p-GS) under the
different conditions tested. The expression levels of total GS
(Fig. 1 A) and the p-GS (Fig. 1 B) were significantly increased in
the retina of normal fasted rats; however, a similar ratio of p-
GS/GS was observed between those of normal and fasted
animals.
The effect of insulin-induced hypoglycemia to induce changes in
glycogen levels in retina was also examined. A single subcutaneous
administration of insulin (5 U/kg) to normal or to diabetic rats
rapidly reduced blood glucose levels. After 1–2 h of insulin
administration to normal rats, blood glucose levels diminished
about 40% to 50%; they increased reaching normal values about
5 h later (Fig. 2). Similarly, insulin administration to diabetic rats
reduced blood glucose levels rapidly, reaching normoglycemic
values in 1–2 h, then values declined to 7066 mg/dl (after 3 h).
Table 1. Glucose-6-phosphate and glycogen content in the
retina of rats under different conditions.
Glucose-6-P Glycogen Blood glucose
Normal (N) 14624 3 641 1 4 64
Fasted (F) 1.860.5* 47688 4 65
F+glucose 82619* 48652 2 3 610*
N+insulin 2.560.1* 48645 5 66*
Diabetic 9568** 142611* 478615*
D+insulin 3.760.1** 2863* 6065*
Normal and 20 day diabetic rats were treated as described in Methods. Normal
(N), normal-fasted rats (F) and normal-fasted rats plus glucose administration
(F+glucose) were sacrificed 2 h after saline or glucose administration. Normal
(N) or diabetic (D) rats were killed after 3 h insulin or saline injection. Glycogen,
nmol glycosyl residues/mg protein; glucose-6-P, pmol/mg protein; glucose, mg/
dl.
*p,0.01;
**p,0.001 with respect to normal rats.
doi:10.1371/journal.pone.0030822.t001
Glycogen Regulation in Retina
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e30822Afterwards, blood glucose levels increased gradually, and levels of
circulating glucose returned to the hyperglycemic state about 12 h
later (Fig. 2).
Following insulin administration, glycogen levels in the retina of
normal rats first decreased (30%), then increased rapidly, reaching
the normal values 2 h after insulin administration, even though
hypoglycemic conditions persisted (55 mg blood glucose/dl) and
G-6-P retina content decreased significantly (Fig. 3). In the retina
of diabetic rats, glycogen content was 80% reduced after 1 h of
insulin injection and remained low 3 h later, time in which
considerable low G-6-P levels were observed (Fig. 3). After 24 h
insulin administration, glycogen content (86612 nmol glycosyl
residues/mg protein) was significantly lower than that found
before insulin administration (142611 nmol glycosyl residues/mg
protein). Moreover, the GS activity was similar to that from
normal rats (Table 2).
Furthermore, the expression levels of GS and p-GS were
decreased in the retina from normal rats after 2 h insulin
Figure 1. Total and phosphorylated GS in retina. Western blot analysis of representative experiments, top panels. (A–D) Graphic
representation of the relative levels of total GS (A, C) and phospho (Ser 641)-GS (B, D). N, normal rat; F, fasted rat; F+G, fasted rat with glucose
administration; N+I, normal rat plus insulin administration; D, 20 day streptozotocin-diabetic rat; D+I, diabetic rat plus insulin injection. Values are the
mean 6 SEM of four experiments. * p,0.05; ** p,0.02.
doi:10.1371/journal.pone.0030822.g001
Table 2. Activity of glycogen synthase and glycogen
phosphorylase in rat retina.
Glycogen synthase Glycogen phosphorylase
Normal 1.0860.06 9.560.9
Diabetic 1.660.12* 10.461.5
Diabetic+insulin 0.960.14 13.663.8
Retina from normal, diabetic, and insulin-treated diabetic animals
(diabetic+insulin) were processed as described in Methods. Activity of glycogen
synthase was measured in the presence of 6.2 mM glucose-6-phosphate.
Activity of glycogen phosphorylase was measured in the presence of 1 mM
AMP. Activities are expressed as nmol/mg protein/min. Values are the means 6
SEM from 5 to 8 rats.
*p,0.01 with respect to the normal rats.
doi:10.1371/journal.pone.0030822.t002
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differences between GS or p-GS were observed in the diabetic
retina after insulin administration. Moreover, no differences in p-
GS/GS ratio were observed between normal or diabetic rat
retinas (Fig.1).
From the present results and the data of an earlier study [7], a
significant correlation (r
2=0.5, p=0.0019) was proved between
the G-6-P content and the activity of GS as well as glycogen levels
in retina (Fig. 4). Similarly, in agreement with previous results [6],
a significant correlation (r
2=0.68, p=0.0001) was observed
between G-6-P and GS activity in liver.
Discussion
The mammalian retina is a very metabolically active tissue
whose energy demands are normally met through the uptake of
glucose and oxygen [12], [13]. Glycogen is the only significant
energy reservoir in nervous tissue; in retina, glycogen and GP are
localized mainly in Muller glial cells [14]. The metabolism of
glucose is intimately linked with glycogen levels. Indeed, glycogen
content in normal retina was seen to fluctuate with the levels of
glucose in the medium [2]. Glycogen content depends on synthesis
and degradation. The regulation of GS activity is known to be
complex [15], [16], [17]. In peripheral tissues, GS activity is
regulated by phosphorylation catalyzed by glycogen synthase
kinase-3 (GSK-3) [3], [4], [15]. In addition, G-6-P concentrations
allosterically activate GS activity [16], but the relative role of these
two events in the regulation of GS activity in vivo is largely
unknown. In brain, glycogen content is influenced by several
neurotransmitters and neuropeptides, including insulin and
norepinephrin [18]. In retina, an increase was observed in
glycogen content as well as in GS activity in ex vivo retinas from
streptozotocin-diabetic rats [7]. Therefore, we focused on
evaluating the possible mechanisms by which glycogen content
in retina is controlled; for this purpose we determined glycogen
and G-6-P in the retina of rats under different experimental
conditions.
Ex vivo retinas from normal rats showed low content of G-6-P
which was even lower in rats under fasting conditions or insulin
administration. These low levels could indicate a high turnover
rate, suggesting G-6-P was rapidly metabolized. In contrast, about
6 times higher levels of G-6-P were found in fasted rats injected
with glucose and in hyperglycemic-diabetic rats, suggesting a
relationship with the high blood glucose levels found in these
animals. Retina glycogen levels were slightly reduced in normal
rats treated with insulin, but they were rapidly recovered although
hypoglycemic conditions remained. These results imply that
glycogen serves as a substantial source of glycosyl units during
insulin-induced hypoglycemia and therefore may be neuroprotec-
tive [19]. In normal retina, in spite of the remarkable changes
observed in G-6-P levels under different experimental conditions,
glycogen content remained almost constant, indicating that
glucose uptake and hexokinase activity were not limiting.
Certainly, the retina shows a high capacity to transport exogenous
glucose, since the Glut1 transporter is widely distributed in this
tissue [20], [21], [22]. These findings may suggest an important
flux of G-6-P to glycogen, suggestive of an insulin role in
Figure 2. Blood glucose levels following insulin administration.
Insulin (5 U/kg) was administered subcutaneously to normal (#) and
diabetic rats ($). Values are the means 6 SEM of at least five different
animals. Standard error in normal rats was less than 5%.
doi:10.1371/journal.pone.0030822.g002
Figure 3. Glucose-6-phosphate lowering patterns and glyco-
gen content in retina following insulin administration. Insulin
(5 U/kg) was administered subcutaneously to normal and 20 day
diabetic rats. (A) G-6-P levels (pmol/mg protein). (B) Glycogen content
(nmol glycosyl residues/mg protein) in retina. Open symbols, diabetic
rats; solid symbols, normal animals. Values are the means 6 SEM of at
least three different animals.
doi:10.1371/journal.pone.0030822.g003
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is unknown, this hormone and its receptors have been reported in
this tissue [23], [24], [25].
In contrast, high G-6-P and glycogen levels were found in the ex
vivo retina from diabetic rats. Notably, G-6-P and glycogen levels
in diabetic retina were dramatically diminished upon insulin
administration and could not be recovered, as occurs in normal
rat. These findings suggest differences in G-6-P metabolism
between normal and diabetic retina. In reference to this, an
interesting finding is that a high lactate retinal content has been
reported in diabetic rats [8]; the increase in lactate could result in
acidosis which may have deleterious effects.
Besides, in spite of the significant changes observed in glycogen
content under the diverse conditions studied, no differences in p-
GS levels were found, which suggests that dephosporylation of GS
was not an involved mechanism. Consistent with this interpreta-
tion, we found a significant correlation of G-6-P levels with GS
activity as well as with glycogen content in retina (Fig. 4).
Therefore, our results indicated that in retina G-6-P caused
allosteric activation of GS, as has been reported in other tissues
[16], [26], and that GS activation in turn led to the elevated
glycogen content observed in diabetic retina. Thus, we conclude
that retina glycogen content served as a glucose reservoir during
periods of hypoglycemia and that its levels were regulated by G-6-
P concentrations. The high levels of glycogen observed in the
streptozotocin–treated rat retina were the result of the hypergly-
cemia, given that circulating glucose levels are the result of glucose
release from liver and its removal from circulation by transport
into muscle. The slow recovery of glycogen content in the retina
from insulin-treated diabetic rats most likely represent a result of
the chronic liver and muscle alterations of glucose disposal
reported in type 1 diabetes [27], [28], [29]. Therefore, since retina
glycogen serves as an energy reservoir, under the hypoglycemia
observed clinically in patients with type-1 diabetes, retinal
neuronal function must be seriously compromised. Supporting
this statement, glycemic control is a major concern in diabetic
patients, particularly those having type 1, who undergo frequent
hypoglycemic episodes [30]. Under these conditions, the glycogen
content in retina would be about 50% of the normal values and
glucose production from glycogen would further support retinal
function only for a short time through glycolytic metabolism.
Indeed, rabbit and rat retinas incubated in the absence of glucose
lead to decline in glycogen [2] and ATP content, and loss of light-
induced electrical signals within 30 min [1]. Although it is clear
that further studies will be needed to decipher the mechanisms,
our results suggest that under the hypoglycemic conditions
observed in diabetes, retinal neuronal survival could be compro-
mised. In this respect, it is remarkable that decrease in retinal
function was found in chronic hypoglycemia produced in an
animal model [31]. Moreover, during the revision of this
manuscript, acute hypoglycemia was reported to induce retinal
cells death in mouse [32] and significant reduction of central
retinal function in humans [33].
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